Literature DB >> 30410693

Delayed Start Protocol with Gonadotropin-releasing Hormone Antagonist in Poor Responders Undergoing In Vitro Fertilization: A Randomized, Double-blinded, Clinical Trial.

Afsoon Zarei1, Mohammad Ebrahim Parsanezhad1, Maryam Azizi Kutenaei1, Bahia Namavar Jahromi1, Parastoo Soheil Esfahani1, Pardis Bakhshaei1.   

Abstract

OBJECTIVES: We sought to determine the effects of the delayed start protocol with gonadotropin-releasing hormone (GnRH) antagonists in poor responders undergoing in vitro fertilization (IVF).
METHODS: This randomized clinical trial was conducted during a 15-month period from April 2014 to July 2015 in clinics in Shiraz, Iran. A total of 42 poor responders with primary infertility were randomly assigned to the controlled ovarian stimulation group utilizing the delayed start protocol (n = 21) or the traditional group (n = 21) using GnRH antagonist, Cetrotide. The primary endpoint was the number of patients undergoing oocyte pick-up, implantation, and the rate of pregnancy.
RESULTS: The baseline characteristics of the two study groups were comparable including age, infertility duration, and body mass index. The number of follicles measuring > 13 mm in diameter (p = 0.057), retrieved oocytes (p = 0.564), mature metaphase II oocytes (p = 0.366), embryos (p = 0.709), and transferred embryos (p = 0.060) were comparable between the two groups. The number of patients undergoing oocyte pick-up (p = 0.311), the rates of implantation (p = 0.407), and pregnancy (p = 0.596) were also comparable between the two groups.
CONCLUSIONS: The delayed start protocol was not associated with better conception results or cycle outcomes in poor responders with primary infertility undergoing IVF cycles.

Entities:  

Keywords:  Gonadotropin-Releasing Hormone; In Vitro Fertilization

Year:  2018        PMID: 30410693      PMCID: PMC6206418          DOI: 10.5001/omj.2018.92

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  33 in total

1.  Prolonged ovarian hyperstimulation for poor responders in in-vitro fertilization treatment cycles.

Authors:  G Ahmad; D I Lewis-Jones; R Gazvani
Journal:  Int J Gynaecol Obstet       Date:  2006-07-07       Impact factor: 3.561

2.  A novel "delayed start" protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders.

Authors:  Hakan Cakmak; Nam D Tran; A Musa Zamah; Marcelle I Cedars; Mitchell P Rosen
Journal:  Fertil Steril       Date:  2014-03-14       Impact factor: 7.329

3.  Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group.

Authors:  C Albano; R E Felberbaum; J Smitz; H Riethmüller-Winzen; J Engel; K Diedrich; P Devroey
Journal:  Hum Reprod       Date:  2000-03       Impact factor: 6.918

Review 4.  The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis.

Authors:  Jinsong Xiao; Shuang Chang; Shuangyun Chen
Journal:  Fertil Steril       Date:  2013-09-19       Impact factor: 7.329

5.  A retrospective evaluation of prognosis and cost-effectiveness of IVF in poor responders according to the Bologna criteria.

Authors:  Andrea Busnelli; Enrico Papaleo; Diana Del Prato; Irene La Vecchia; Eleonora Iachini; Alessio Paffoni; Massimo Candiani; Edgardo Somigliana
Journal:  Hum Reprod       Date:  2014-11-28       Impact factor: 6.918

6.  The outcome of IVF-embryo transfer treatment in patients who develop three follicles or less.

Authors:  M M Biljan; W M Buckett; N Dean; S J Phillips; S L Tan
Journal:  Hum Reprod       Date:  2000-10       Impact factor: 6.918

7.  Expected poor ovarian response in predicting cumulative pregnancy rates: a powerful tool.

Authors:  Dave J Hendriks; Egbert R te Velde; Caspar W N Looman; László F J M M Bancsi; Frank J M Broekmans
Journal:  Reprod Biomed Online       Date:  2008-11       Impact factor: 3.828

8.  Common carotid intima-media thickness in patients with non-alcoholic fatty liver disease: a population-based case-control study.

Authors:  Kamran B Lankarani; Mojtaba Mahmoodi; Mehrzad Lotfi; Nima Zamiri; Sayed Taghi Heydari; Fariborz Ghaffarpasand; Mohammad Kazem Fallahzadeh; Meisam Babaeinejad; Najmeh Maharlouei; Omid Mirzaee; Bita Geramizadeh; Payam Peymani
Journal:  Korean J Gastroenterol       Date:  2013-12

9.  Hormonal regulation of apoptosis in early antral follicles: follicle-stimulating hormone as a major survival factor.

Authors:  S Y Chun; K M Eisenhauer; S Minami; H Billig; E Perlas; A J Hsueh
Journal:  Endocrinology       Date:  1996-04       Impact factor: 4.736

10.  Empty Follicle Syndrome: The Possible Cause of Occurrence.

Authors:  Tahereh Madani; Nadia Jahangiri
Journal:  Oman Med J       Date:  2015-11
View more
  2 in total

Review 1.  Efficacy of the delayed start antagonist protocol for controlled ovarian stimulation in Bologna poor ovarian responders: a systematic review and meta-analysis.

Authors:  Shuang Yang; Nenghui Liu; Yanping Li; Lei Zhang; Rongya Yue
Journal:  Arch Gynecol Obstet       Date:  2020-11-24       Impact factor: 2.344

Review 2.  Ovarian stimulation protocols for poor ovarian responders: a network meta-analysis of randomized controlled trials.

Authors:  Man Di; Xiaohong Wang; Jing Wu; Hongya Yang
Journal:  Arch Gynecol Obstet       Date:  2022-06-11       Impact factor: 2.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.